BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4458 related articles for article (PubMed ID: 3127037)

  • 1. Half-lives of tyrosinase isozymes from Harding-Passey mouse melanoma.
    Martinez JH; Solano F; Peñafiel R; Lozano JA
    Cancer Lett; 1988 Jan; 38(3):339-46. PubMed ID: 3127037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for mammalian tyrosinase: a comparative study.
    Jara JR; Solano F; Lozano JA
    Pigment Cell Res; 1988; 1(5):332-9. PubMed ID: 2907130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of endogenous proteases on the distribution of tyrosinase isozymes in Harding-Passey mouse melanoma.
    Martinez JH; Solano F; Lozano JA
    Cell Biochem Funct; 1989 Jan; 7(1):21-6. PubMed ID: 2502324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microheterogeneity of melanosome-bound tyrosinase from the Harding-Passey murine melanoma.
    Ferrini U; Mileo AM; Hearing VJ
    Int J Biochem; 1987; 19(3):227-34. PubMed ID: 3109972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The existence of apotyrosinase in the cytosol of Harding-Passey mouse melanoma melanocytes and characteristics of enzyme reconstitution by Cu(II).
    Martínez JH; Solano F; Arocas A; García-Borrón JC; Iborra JL; Lozano JA
    Biochim Biophys Acta; 1987 Mar; 923(3):413-20. PubMed ID: 3103692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of polyamines on tyrosinase activity.
    Galindo JD; Martinez JH; Lopez-Ballester JA; Peñafiel R; Solano F; Lozano JA
    Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinase of hamster melanoma: its purification and estimation by radioimmunoassay.
    Vachtenheim J; Duchon J; Matous B
    Comp Biochem Physiol B; 1987; 87(4):709-14. PubMed ID: 3117484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
    Tomita Y; Hariu A; Kato C; Seiji M
    Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hazard in tyrosinase assays.
    Bennett DC
    J Invest Dermatol; 1989 Nov; 93(5):709. PubMed ID: 2507646
    [No Abstract]   [Full Text] [Related]  

  • 11. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-selective action of 4-hydroxyanisole on melanoma cells in vivo.
    Schwabe K; Fichtner I; Tschiersch B
    Pigment Cell Res; 1990; 3(1):8-10. PubMed ID: 2116000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model for the survival of tyrosinase isozymes in serum.
    Vachtenheim J; Duchon J; Matous B
    Arch Dermatol Res; 1984; 276(2):111-4. PubMed ID: 6426408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma.
    Garcia-Borron JC; Solano F; Iborra JL; Lozano JA
    Biochem J; 1985 May; 228(1):95-101. PubMed ID: 3924035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinase isozyme heterogeneity in differentiating B16/C3 melanoma.
    Laskin JD; Piccinini LA
    J Biol Chem; 1986 Dec; 261(35):16626-35. PubMed ID: 3097004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New regulators of melanogenesis are associated with purified tyrosinase isozymes.
    Hearing VJ; Korner AM; Pawelek JM
    J Invest Dermatol; 1982 Jul; 79(1):16-8. PubMed ID: 6806397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
    García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
    Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of two melanocytolytic agents, hydroquinone and beta-mercaptoethanolamine, upon tyrosinase activity and cyclic nucleotide levels in murine melanomas.
    Abramowitz J; Chavin W
    Chem Biol Interact; 1980 Oct; 32(1-2):195-208. PubMed ID: 6253089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 223.